Press release
Paclitaxel Injection Market Trends and Opportunities by 2016 – 2026
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/12697
The increasing prevalence of cancer is the major driving factor for the significant growth of this market. Paclitaxel injection has better efficiency for the treatment of cancer than other medication, besides that this is also easily available in the market which is responsible for the growth of this market. Major players of paclitaxel injection market are focusing on development of more improved paclitaxel injection which will be a remarkable opportunity for this market to grow. Several adverse effects such as blood clot, allergy, leucopenia, diarrhea and weight loss can restrain the growth of paclitaxel injection market. The high cost of drug, which is less affordable in low economic countries can also hinder the growth of paclitaxel injection market.
Segmentation
The global market of paclitaxel injection is segmented on the basis of indication, end users and geographical region.
Segmentation by Indication
Breast Cancer
Cervical Cancer
Ovarian Cancer
Stomach Cancer
Prostate Cancer
Lungs Cancer
Esophageal Cancer
Testicular Cancer
Pancreatic Cancer
AIDS related Kaposi’s Sarcoma
Others
Segmentation by End User
Hospitals
Clinics
Cancer Research Institute
Segmentation by Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Paclitaxel injection market is expected show substantial growth over the forecast period. According to World Health Organization, in 2012 around 8.2 million died due to cancer globally. Based on indication paclitaxel injection market is segmented as breast cancer, ovarian cancer, cervical cancer, prostate cancer, lungs cancer, stomach cancer and other. From all indication, breast cancer segment is expected to gain maximum share for paclitaxel injection market due to growing incidences of breast cancer. Based on the end user, paclitaxel injection market is classified as hospital, clinics, and cancer research institute. Among all end user, hospital segment is expected to gain maximum share for paclitaxel injection market.
On the basis of regional presence, global paclitaxel injection market is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America is expected to dominate the paclitaxel injection market due to high prevalence of breast cancer and stomach cancer. Europe and Asia-Pacific then follow this market. Asia-Pacific region is projected to show remarkable growth for paclitaxel injection market. In Asia-Pacific, India and China are major markets due to high population. Paclitaxel injection is the second largest pharmaceutical market in China.
Some of the major players in paclitaxel injection market are Abbott Laboratories, Pfizer, Inc., Fresenius Kabi SE & Co. KGaA., Strides Arcolab Limited, Sagent Pharmaceuticals, Inc. Bristol-Myers Squibb Company, Celgene Corporation, Taj Accura Pharmaceuticals, Khandelwal Laboratories Pvt. Lmt., Luye Pharma Group, Youcare Pharmaceutical Group Co., Ltd. and BEIJING Union Pharmaceutical Factory.
To view complete report @http://www.persistencemarketresearch.com/market-research/paclitaxel-injection-market.asp
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Paclitaxel Injection Market Trends and Opportunities by 2016 – 2026 here
News-ID: 640049 • Views: …
More Releases from Persistence Market Research
Global Supply Chain Management BPO Market to Reach US$ 58 Bn by 2032
The Supply Chain Management BPO Market is experiencing a transformative phase as businesses increasingly recognize the strategic advantages of outsourcing non-core supply chain operations. The global market is forecast to grow at a CAGR of 8.6%, expanding from US$32.5 billion in 2025 to reach approximately US$58 billion by 2032. Supply chain management business process outsourcing (BPO) refers to the practice of delegating comprehensive supply chain operations-ranging from procurement, logistics, inventory…
Healthcare Cloud Computing Market to Reach US$ 197.4 Bn by 2032 at 17.3% CAGR
Overview of the Healthcare Cloud Computing Market
The global healthcare cloud computing market is poised for significant expansion, with an estimated valuation of US$63.5 billion in 2025, projected to reach US$197.4 billion by 2032 at a robust CAGR of 17.3%. This rapid growth is largely fueled by the increasing adoption of cloud infrastructure to enhance data accessibility, facilitate telehealth services, and integrate artificial intelligence (AI) into healthcare analytics. Healthcare organizations are…
Global Big Data Storage Market to Grow at 13% CAGR Through 2032
The global storage in big data market is undergoing a transformative expansion as organizations generate and process massive volumes of data from diverse sources such as IoT devices, digital transactions, and connected platforms. The market is projected to be valued at US$63.4 billion in 2025 and is anticipated to reach US$132 billion by 2032, registering an impressive CAGR of 13% during the forecast period (2025-2032). This growth is primarily driven…
U.S. Internet of Things (IoT) Market to Reach $609.2 Billion by 2032, Driven by …
The U.S. Internet of Things (IoT) market is experiencing rapid growth, driven by accelerating digital transformation across industries and increasing adoption of connected devices. Valued at US$ 142.2 billion in 2024, the market is expected to reach US$ 169.0 billion in 2025 and further expand at an impressive CAGR of 20.1% to reach US$ 609.2 billion by 2032. The United States currently accounts for nearly 20% of the global IoT…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
